MicroRNA-19b Promotes Nasopharyngeal Carcinoma More Sensitive to Cisplatin by Suppressing KRAS
Open Access
- 1 January 2018
- journal article
- research article
- Published by SAGE Publications in Technology in Cancer Research & Treatment
- Vol. 17
Abstract
MicroRNAs have been reported to play a vital role in diverse biological processes and tumorigenesis. MicroRNA-19b-5p has been observed to be downregulated in other cancers, but the function of microRNA-19b-5p in human nasopharyngeal carcinoma has not been well investigated. In our study, these results demonstrated that microRNA-19b-5p was significantly downregulated in 37 pairs of nasopharyngeal carcinoma tissues when compared to normal tissues. Enforced expression of microRNA-19b-5p inhibited activity of cell proliferation and cell migration of nasopharyngeal carcinoma cancer cells, CNE1 and HNE1. Furthermore, microRNA-19b-5p targeted KRAS proto-oncogene, GTPase in cancer cells. In human clinical specimens, KRAS was higher expressed in cancer tissues when compared with normal tissues, which was inversely correlated with the expression of microRNA-19b-5p. More interestingly, microRNA-19b-5p sensitizes CNE1 cells to cisplatin by inhibiting its target KRAS. Finally, microRNA-19b-5p inhibits tumorigenesis in vivo. Thus, our results investigated that microRNA-19b-5p functioned as a tumor suppressor and indicated its potential application for the treatment of human nasopharyngeal carcinoma in future.Keywords
This publication has 24 references indexed in Scilit:
- Computerised Cognitive Behavioural Therapy for Insomnia: A Systematic Review and Meta-AnalysisPsychotherapy and Psychosomatics, 2012
- How Does Intensity-Modulated Radiotherapy Versus Conventional Two-Dimensional Radiotherapy Influence the Treatment Results in Nasopharyngeal Carcinoma Patients?International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- miR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRASMolecular and Cellular Biochemistry, 2011
- A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell SubpopulationsCell, 2010
- Ras promotes cell survival by antagonizing both JNK and Hid signals in the DrosophilaeyeBMC Developmental Biology, 2009
- MicroRNA Signatures in Human CancersNature Reviews Cancer, 2006
- MicroRNAs: small RNAs with a big role in gene regulationNature Reviews Genetics, 2004
- MicroRNAsCell, 2004
- A genome-wide survey of RAS transformation targetsNature Genetics, 2000
- Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras geneNature, 1982